| 영문 | chronic lymphocytic leukemia | 한글 | 만성림프성 백혈병 |
|---|---|---|---|
| 설명 | 백혈병(leukemia)란 비정상적인 백혈구 세포의 증식에 의해 일어나는 병적인 상태를 말하는데, 흔히 말초혈액에 미분화세포가 나타나며, 정상적인 적혈구세포와 백혈구세포, 혈소판의 급격한 감소를 가져와 정상적인 세포에 의해 행해지는 여러 기능의 감소를 주증상으로 하여 병원에 찾아오게 된다. 따라서 적혈구세포의 감소로 인한 빈혈, 백혈구세포의 감소로 인한 많은 감염증세(흔히 걸리지 않는 세균에 의한 감염, 지나치게 잦은 감기, 폐렴 등), 혈소판세포의 감소로 인한 출혈증상이 나타난다. 또한 피를 생산하는 골수 조직에서는 이런 비정상적인 세포의 증식만을 볼 수 있으며, 정상적인 세포의 증식은 보기 힘들다. 만성림프성 백혈병은 서양에서는 비교적 백혈병 중에서 흔한 형이지만 동양권에서는 아주 드문 백혈병의 형태이다. 대개 60세 이상의 고령층에서 많이 생기고 30세 이하에서는 거의 찾아볼 수가 없다. 혈액검사상에서 림프구의 많은 증가를 볼 수가 있고, 대신에 다른 혈액세포들은 감소를 나타낸다. 백혈병 중 예후가 좋은 편이며 대개 치료는 항암제를 이용한 화학요법을 많이 사용하며, 평균 생존기간은 4~5년이다. |
||
| 영문 | acute hepatitis | 한글 | 급성간염 |
|---|---|---|---|
| 설명 | 바이러스에 의해 간에 생기는 급성염증. 급성간염이란 간염바이러스(A형-B형-비A비B형)에 의해서 간에 생기는 급성염증을 병명으로 이르는 말로, 이는 그 감염양식에 수혈 후에 발생하는 수혈후 간염과, 감염경로를 알 수 없는 산발성간염 및 집단으로 발생하는 유행선간염의 세가지 유형으로 나눌 수 있다. 수혈후 간염은 그 95%가 비A비B형간염이며 나머지가 B형 간염이다. 산발성 간염은 A형 간염과 B형 간염이 각각 30%를 이루고 나머지 40%는 비A비B간염이다. 집단으로 발생하는 유행성간염은 거의가 A형간염이지만 때로는 여기에 포함되지 않은 형의 간염일 경우도 있다. 급성간염의 증세는 먼저 몸이 나른해지고 온몸에 권태감이 찾아오며 조그마한 일에도 곧 피로를 느끼게 된다. 그리고 식욕부진-발열-구토증-복통-설사 등, 감기나 급성위장염에 걸렸을 때와 같은 증세 등이 나타난다. 뒤이어 황달증세를 보이는데, 이때는 초기의 증세가 약간 가벼워진 것처럼 느껴지는 것이 보통이다. 그러나 황달증세가 심해지고 초기의 증세들이 다시 진행되면 이때는 전격성간염이 될 위험이 있다. 간염 증세가 심하지 않았을 경우는 황달이 눈에 띄지 않은 경우도 있는데 이때는 진찰을 해도 감기나 급성위창자염으로 자칫 오진되기 쉽다. 또 A형간염은 열이 38~39℃까지 오르고 증세가 갑자기 나타나는 것이 특징이며 급성비A비B형간염은 증세가 비교적 가벼운 것이 특징이다. 급성B형간염의 증세는 A형간염과 급성비A비B형간염의 중간 정도인 것이 보통이다. |
||
| 영문 | acute appendicitis | 한글 | 급성막창자꼬리염 |
|---|---|---|---|
| 설명 | 외과적 처치를 요하는 막창자꼬리(충수)의 급성염증으로서, 보통 하복부의 오른쪽 1/4 부위에서의 통증이 특징이며, 국소압통, 근육긴장 피부감각의 과민 등을 수반한다. 일반딘들이 “맹장염”이라고 하는 것으로 맹장염은 막창자의 염증으로 구별되어야 한다. 발열과 다형백혈구증다는 국소감염의 결과이다. 막창자꼬리의 위치-유착상태-꼬임 등에 의해 증상과 징후는 변동된다. |
||
| 영문 | acute cholecystitis | 한글 | 급성쓸개염 |
|---|---|---|---|
| 설명 | 보통 쓸개 출구의 폐색에 의한 것이며, 염증의 정도는 경도의 부종으로부터 괴저와 천공을 수반하는 감염증까지 있다. |
||
| 영문 | severe acute respiratory syndrome(SARS) | 한글 | 사스 |
|---|---|---|---|
| 설명 | 중국 광동 지역에서 가장 먼저 발생한 전염성 호흡기 질환으로 세계보건기구(WHO)에서 ‘중증급성호흡증후군(SARS)'으로 명명했다. 섭씨 38도 이상의 고열과 기침, 호흡곤란, 저산소증, X선상의 폐렴증상 중 하나 이상의 증상이 나타나며, 두통, 근육통, 식욕부진, 피로감, 발진, 설사를 동반할 수 있다. 초기 증상은 감기와 비슷하지만 폐렴으로 발전하면 치명적일 수 있다. 현재 밝혀진 감염경로는 환자가 재채기나 기침할 때 내뿜는 침방울이고, 이것이 다른 사람의 호흡기로 들어갈 때 전염된다. 침방울이 전달되는 거리는 보통 1m로 보고 있다. 공기를 통해 전염이 가능하다는 주장이 제기됐지만 아직 확인되지 않았다. 원인균은 변종 코로나바이러스로 밝혀졌다. |
||
| AML | Acute Myelogenous Leukemia Morphologic Classification(FAB분류) &n... |
|---|---|
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
| AML | acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukem... |
| AP | accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p... |
| ALL | acute lymphoblastic leukemia; acute lymphocytic leukemia |
| ALL | Acute Lymphocytic Leukaemia |
|---|---|
| B CLL | B chronic lymphocytic leukaemia |
| B-CLL | B type chronic lymphocytic leukaemia |
| CLL | B-chronic lymphocytic leukaemia |
| B-CLL | B-lymphocytic leukaemia |
acute angle
acute arthritis
acute monocytic leukemia
acute allergic reaction (급성 과민성 반응
| acute lymphocytic leukaemia | <radiology> 95% of cases of leukaemia in children, bone changes in 50-70% of kids (vs. 10% in adults); seen as early as 1 month after onset of symptoms, wrists and knees most commonly affected, bony defects: metaphyseal radiolucent bands! (similar findings in scurvy, JRA, syphilis), osteolytic lesions, periosteal reaction, osteosclerosis (12 Dec 1998) |
|---|
| acute non-lymphocytic leukaemia | <haematology> A form of leukaemia which is characterised by the proliferation of immature bone marrow precursor cells in the marrow and immature white blood cells (granulocytes) in the bloodstream. Occurs primarily in adults and in infants under 1 year of age. Complications include abnormal bleeding and susceptibility to infections. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Trisomy-8 is the most common cytogenetic abnormality observed, followed by monosomy-7 and monosomy-5. Approximately 8% of cases show trisomy-8, mostly in AML (M1), AM (M4) and acute monocytic leukaemia (M5). Many pre-leukaemic conditions, acute non-lymphocytic leukaemia and secondary leukemia show monosomy-7 or deletion of the long arm of chromosome 7. Treatment includes chemotherapy and/or bone marrow transplant. Acronym: ANLL Incidence: 2.5 cases per 100,000 (all ages). Origin: Gr. Haima = blood (07 Apr 1998) |
|---|---|
| chronic lymphocytic leukaemia | <haematology> A slowly progressing form of leukaemia, characterised by an increased number of the type of white blood cell known as lymphocytes. With about 3, 500 new cases occurring each year in the UK, it is the most common form of leukaemia and occurs predominantly in late middle age onwards. It has variable symptoms and course, but may be diagnosed by chance before the patient develops any clinical symptoms of disease. Acronym: CLL Origin: Gr. Haima = blood (12 Jan 1998) |
| leukaemia, lymphocytic | Leukaemia associated with hyperplasia and overactivity of the lymphoid tissue. There are increased numbers of circulating malignant lymphocytes and lymphoblasts. (12 Dec 1998) |
| lymphocytic leukaemia | <haematology, oncology> An acute form of childhood leukaemia characterised by the development of abnormal cellsdevelop in the bone marrow and lymphoblasts are found in blood-formingtissues. A type of chronic leukaemia found most often in the elderly, it is characterised by the presence of mature lymphocytes in the blood. Origin: Gr. Haima = blood (13 Nov 1997) |
| acute granulocytic leukaemia | <haematology> A form of leukaemia which is characterised by the proliferation of immature white blood cells (granulocytes) in the bloodstream. Occurs primarily in adults and in infants under 1 year of age. Complications include abnormal bleeding and susceptibility to infections. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Treatment includes chemotherapy and/or bone marrow transplant. Origin: Gr. Haima = blood (27 Sep 1997) |
| acute leukaemia | <haematology> A rapidly progressive cancer of the blood of sudden onset and characterised by the uncontrolled proliferation of immature blood cells which take over the bone marrow and spill into the blood stream. If left untreated is fatal within a few weeks or months. See: acute lymphoblastic leukaemia, acute myeloid leukaemia. Origin: Gr. Haima = blood (11 Nov 1997) |
| acute lymphoblastic leukaemia | <haematology> A rapidly progressing cancer of the blood affecting the type of white blood cell known as lymphocytes. Approximately 650 new cases are diagnosed every year in the UK and it is the most common form of childhood leukaemia. Acronym: ALL Origin: Gr. Haima = blood (11 Nov 1997) |
| acute monocytic leukaemia | <haematology> The most common translocation in this disorder of poorly differentiated monocytic cells involves chromosome region 11q in a large percentage of cases. The translocation involves a cellular oncogene, c-ets which is mapped to the 11q23-24 region. The most common translocations reported are t(6;11), t(9;11), t(11;17) and t(11;19), of which t(9;11) (p21-22;q23) is by far the most frequently detected and implicated in acute myeloid leukaemia. The cells express CD14 surface antigen, which is diagnostic of monocytic cells. Acronym: AML Classification: FAB M5 (07 Apr 1998) |
| acute myeloblastic leukaemia | <haematology> A rapidly progressing cancer of the blood affecting immature cells of the bone marrow, usually of the white cell population. It is much more common in adults than in children. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Treatment includes chemotherapy and/or bone marrow transplant. This leukaemia demonstrates granulocyte differentiation, eosinophilia and Auer rods and is associated with a reciprocal translocation between 8 and 21 (q22;q22), which is the most common translocation in acute myeloid leukaemia and is found more often in younger patients than in older patients. The oncogene involved in this translocation is AML1, which can be detected by Southern blot. Numerical abnormalities, particularly monosomy-7, trisomy-4, trisomy-8, trisomy-21, -Y, monosomy-7 and deletions of the long arms of chromosomes 5 and 7 are quite common in all acute myeloid leukaemia and not restricted to any one FAB classification. Many of these abnormalities are observed at diagnosis and at later stage disease, particularly after chemotherapy. Prognosis is generally more favorable than in FAB-M2 patients showing no translocation, because the latter patients show better remission rates for longer periods of time. Immunophenotyping is useful in diagnosis and expression of one or more of the myeloid antigens CD13, CD14 or CD33 must be detected to make a diagnosis of acute myeloid leukaemia. Acronym: AML Incidence: 2,000 new cases per year in the UK. Origin: Gr. Haima = blood (07 Apr 1998) |
| acute myelogenous leukaemia | <haematology> A rapidly progressing cancer of the blood affecting immature cells of the bone marrow, usually of the white cell population. It is much more common in adults than in children. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Treatment includes chemotherapy and/or bone marrow transplant. This leukaemia demonstrates granulocyte differentiation, eosinophilia and Auer rods and is associated with a reciprocal translocation between 8 and 21 (q22;q22), which is the most common translocation in acute myeloid leukaemia and is found more often in younger patients than in older patients. The oncogene involved in this translocation is AML1, which can be detected by Southern blot. Numerical abnormalities, particularly monosomy-7, trisomy-4, trisomy-8, trisomy-21, -Y, monosomy-7 and deletions of the long arms of chromosomes 5 and 7 are quite common in all acute myeloid leukaemia and not restricted to any one FAB classification. Many of these abnormalities are observed at diagnosis and at later stage disease, particularly after chemotherapy. Prognosis is generally more favorable than in FAB-M2 patients showing no translocation, because the latter patients show better remission rates for longer periods of time. Immunophenotyping is useful in diagnosis and expression of one or more of the myeloid antigens CD13, CD14 or CD33 must be detected to make a diagnosis of acute myeloid leukaemia. Acronym: AML Incidence: 2,000 new cases per year in the UK. Origin: Gr. Haima = blood (07 Apr 1998) |
| acute myeloid leukaemia | <haematology> A rapidly progressing cancer of the blood affecting immature cells of the bone marrow, usually of the white cell population. It is much more common in adults than in children. Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains. Treatment includes chemotherapy and/or bone marrow transplant. This leukaemia demonstrates granulocyte differentiation, eosinophilia and Auer rods and is associated with a reciprocal translocation between 8 and 21 (q22;q22), which is the most common translocation in acute myeloid leukaemia and is found more often in younger patients than in older patients. The oncogene involved in this translocation is AML1, which can be detected by Southern blot. Numerical abnormalities, particularly monosomy-7, trisomy-4, trisomy-8, trisomy-21, -Y, monosomy-7 and deletions of the long arms of chromosomes 5 and 7 are quite common in all acute myeloid leukaemia and not restricted to any one FAB classification. Many of these abnormalities are observed at diagnosis and at later stage disease, particularly after chemotherapy. Prognosis is generally more favorable than in FAB-M2 patients showing no translocation, because the latter patients show better remission rates for longer periods of time. Immunophenotyping is useful in diagnosis and expression of one or more of the myeloid antigens CD13, CD14 or CD33 must be detected to make a diagnosis of acute myeloid leukaemia. Acronym: AML Incidence: 2,000 new cases per year in the UK. Origin: Gr. Haima = blood (07 Apr 1998) |
| acute promyelocytic leukaemia | Leukaemia presenting as a severe bleeding disorder, with infiltration of the bone marrow by abnormal promyelocytes and myelocytes, a low plasma fibrinogen, and defective coagulation. (05 Mar 2000) |
| common acute lymphoblastic leukaemia | <haematology, oncology> A sub-type of acute lymphoblastic leukaemia affecting cells early in the B lymphocyte lineage which accounts for about 80% of all acute lymphoblastic leukaemia. Origin: Gr. Haima = blood (13 Nov 1997) |
| leukaemia, erythroblastic, acute | A myeloproliferative disorder characterised by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. (12 Dec 1998) |
| leukaemia, megakaryocytic, acute | Nonlymphocytic leukaemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|